Improvement of hyponatremia is associated with lower mortality risk in patients with acute decompensated heart failure: a meta-analysis of cohort studies

被引:21
作者
Wang, Jinhui [1 ]
Zhou, Weijian [1 ]
Yin, Xiaoning [2 ]
机构
[1] Weihai Municipal Hosp, Dept Cardiol, 70 Heping Rd, Weihai 264200, Peoples R China
[2] Weihai Municipal Hosp, Dept Intervent Med, Weihai 264200, Peoples R China
关键词
Hyponatremia; Heart failure; Mortality; Cohort studies; Meta-analysis; SERUM SODIUM CONCENTRATION; MANAGEMENT; TOLVAPTAN; IMPACT; HOSPITALIZATION; HETEROGENEITY; ACTIVATION; OUTCOMES;
D O I
10.1007/s10741-018-9753-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hyponatremia at admission is predictive of poor prognosis in patients with acute decompensated heart failure (ADHF). We performed a meta-analysis of cohort studies to evaluate whether improvement of hyponatremia is associated with improved survival in patients with ADHF and hyponatremia. Relevant studies were identified through systematic search of PubMed and Embase. A random-effect model was used to pool the results. Predefined subgroup analyses were performed to explore the source of heterogeneity. Five thousand seven hundred fourteen patients with ADHF and hyponatremia from eight cohort studies were included. Results showed that improvement of hyponatremia during hospitalization was associated with lower risk of all-cause mortality (RR=0.65, 95% CI 0.53 to 0.80, p<0.001) as compared with those without improvement of hyponatremia. Results of subgroup analyses indicated that improvement of hyponatremia was associated with more remarkable changes of short-term (within 3months after discharge) mortality (RR=0.54) as compared with long-term mortality (RR=0.74). Other factors such as study design, sample size, and heart failure subtypes did not affect the association. This was further confirmed by the meta-analysis of studies with multivariate analysis, which also suggested an association between improved hyponatremia and lower risk of all-cause mortality in ADHF patients (adjusted RR=0.63, 95% CI 0.43 to 0.92, p=0.02; I-2=63%). These results suggested that improvement of hyponatremia in ADHF patients is associated with lower mortality risk during follow-up, particularly for the short-term mortality.
引用
收藏
页码:209 / 217
页数:9
相关论文
共 34 条
[1]   Tolvaptan for Heart Failure, Systematic Review and Meta-Analysis of Trials [J].
Alskaf, E. ;
Tridente, A. ;
Al-Mohammad, A. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 68 (03) :196-203
[2]  
[Anonymous], 2016, NEWCASTLEOTTAWA SCAL
[3]  
Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI [10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000530]
[4]   Moderate Hyponatremia Is Associated with Increased Risk of Mortality: Evidence from a Meta-Analysis [J].
Corona, Giovanni ;
Giuliani, Corinna ;
Parenti, Gabriele ;
Norello, Dario ;
Verbalis, Joseph G. ;
Forti, Gianni ;
Maggi, Mario ;
Peri, Alessandro .
PLOS ONE, 2013, 8 (12)
[5]  
DARGIE HJ, 1987, CIRCULATION, V75, P98
[6]   Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure [J].
Donze, Jacques D. ;
Beeler, Patrick E. ;
Bates, David W. .
AMERICAN JOURNAL OF MEDICINE, 2016, 129 (08) :836-842
[7]   Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry) [J].
Dunlap, Mark E. ;
Hauptman, Paul J. ;
Amin, Alpesh N. ;
Chase, Sandra L. ;
Chiodo, Joseph A., III ;
Chiong, Jun R. ;
Dasta, Joseph F. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (08)
[8]   PROSTAGLANDINS IN SEVERE CONGESTIVE HEART-FAILURE - RELATION TO ACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM AND HYPONATREMIA [J].
DZAU, VJ ;
PACKER, M ;
LILLY, LS ;
SWARTZ, SL ;
HOLLENBERG, NK ;
WILLIAMS, GH .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (06) :347-352
[9]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[10]   Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure - Results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial [J].
Gattis, WA ;
O'Connor, CM ;
Gallup, DS ;
Hasselblad, V ;
Gheorghiade, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (09) :1534-1541